These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3092617)

  • 1. Electrophysiology in assessing supraventricular arrhythmias: value of programmed stimulation in predicting and understanding efficacy of encainide.
    Wellens HJ; Brugada P
    Am J Cardiol; 1986 Aug; 58(5):37C-40C. PubMed ID: 3092617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of incessant supraventricular tachycardia by intravenous and oral encainide.
    Brugada P; Abdollah H; Wellens HJ
    J Am Coll Cardiol; 1984 Dec; 4(6):1255-60. PubMed ID: 6438205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
    Kunze KP; Kuck KH; Schlüter M; Kuch B; Bleifeld W
    Am J Cardiol; 1984 Aug; 54(3):323-9. PubMed ID: 6431796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptoms.
    Horowitz LN
    Am J Cardiol; 1986 Aug; 58(5):83C-86C. PubMed ID: 3092624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiology of oral encainide.
    Jackman WM; Zipes DP; Naccarelli GV; Rinkenberger RL; Heger JJ; Prystowsky EN
    Am J Cardiol; 1982 Apr; 49(5):1270-8. PubMed ID: 6801954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH; Kunze KP; Schlüter M; Duckeck W
    Am J Cardiol; 1988 Dec; 62(19):37L-44L. PubMed ID: 3144166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM; Lee JT; Woosley RL; Echt DS
    Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
    Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
    Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentry.
    Miles WM; Chang MS; Heger JJ; Rinkenberger RL; Zipes DP; Prystowsky EN
    Am Heart J; 1987 Jul; 114(1 Pt 1):26-33. PubMed ID: 3111237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of encainide and flecainide on chronic ectopic atrial tachycardia.
    Kunze KP; Kuck KH; Schlüter M; Bleifeld W
    J Am Coll Cardiol; 1986 May; 7(5):1121-6. PubMed ID: 3082957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
    Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of supraventricular arrhythmias with encainide.
    Pool PE
    Am J Cardiol; 1986 Aug; 58(5):55C-57C. PubMed ID: 3092621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic and clinical effects of oral encainide in paroxysmal atrioventricular node reentrant tachycardia.
    Chimienti M; Li Bergolis M; Moizi M; Salerno JA
    J Am Coll Cardiol; 1989 Oct; 14(4):992-8. PubMed ID: 2507613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and electrophysiologic effects of encainide in patients with bundle branch block.
    Schwartz AB; Shapiro WA; Suave MJ; Shen E; Bhandari A; Morady F; Scheinman M
    Can J Cardiol; 1987 Mar; 3(2):75-82. PubMed ID: 3105850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encainide for treatment of supraventricular tachycardias associated with the Wolff-Parkinson-White syndrome.
    Markel ML; Prystowsky EN; Heger JJ; Miles WM; Fineberg N; Zipes DP
    Am J Cardiol; 1986 Aug; 58(5):41C-48C. PubMed ID: 3092619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encainide for refractory supraventricular tachycardia in children.
    Strasburger JF; Moak JP; Smith RT; McVey-Duncan P; Armstrong K; Garson A
    Am J Cardiol; 1986 Aug; 58(5):49C-54C. PubMed ID: 3092620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophysiological effects of encainide in man].
    Cassagneau B; Calazel J; Puel J; Massabuau P; Miquel JP; Bounhoure JP; Marin T; Narula OS
    Arch Mal Coeur Vaiss; 1984 Jun; 77(6):707-11. PubMed ID: 6431937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to encainide of refractory ventricular tachycardia: clinical application of assays for parent drug and metabolites.
    Anderson JL; Stewart JR; Johnson TA; Lutz JR; Pitt B
    J Cardiovasc Pharmacol; 1982; 4(5):812-9. PubMed ID: 6182414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
    Miles WM; Zipes DP; Rinkenberger RL; Markel ML; Prystowsky EN; Dougherty AH; Heger JJ; Naccarelli GV
    Am J Cardiol; 1988 Dec; 62(19):20L-25L. PubMed ID: 3144163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.